(LYRA) – FDA
-
Lyra Therapeutics (LYRA) Resumes Trading, Up 28% Following Positive Results
-
Lyra Therapeutics (LYRA) Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220
-
-
-
-
-
-
-
-
-
Back to LYRA Stock Lookup